Literature DB >> 22781090

A unique MSH2 exon 8 deletion accounts for a major portion of all mismatch repair gene mutations in Lynch syndrome families of Sardinian origin.

Iolanda Borelli1, Marco A Barberis, Francesca Spina, Guido C Casalis Cavalchini, Caterina Vivanet, Luisa Balestrino, Monica Micheletti, Anna Allavena, Paola Sala, Carlo Carcassi, Barbara Pasini.   

Abstract

Lynch syndrome is an autosomal-dominant hereditary condition predisposing to the development of specific cancers, because of germline mutations in the DNA-mismatch repair (MMR) genes. Large genomic deletions represent a significant fraction of germline mutations, particularly among the MSH2 gene, in which they account for 20% of the mutational spectrum. In this study we analyzed 13 Italian families carrying MSH2 exon 8 deletions, 10 of which of ascertained Sardinian origin. The overrepresentation of Sardinians was unexpected, as families from Sardinia account for a small quota of MMR genes mutation tests performed in our laboratory. The hypothesis that such a result is owing to founder effects in Sardinia was tested by breakpoint junctions sequencing and haplotype analyses. Overall, five different exon eight deletions were identified, two of which recurrent in families, all apparently unrelated, of Sardinian origin (one in eight families, one in two families). The c.1277-1180_1386+2226del3516insCATTCTCTTTGAAAA deletion shares the same haplotype between all families and appears so far restricted to the population of South-West Sardinia, showing the typical features of a founder effect. The three non-Sardinian families showed three different breakpoint junctions and haplotypes, suggesting independent mutational events. This work has useful implications in genetic testing for Lynch syndrome. We developed a quick test for each of the identified deletions: this can be particularly useful in families of Sardinian origin, in which MSH2 exon 8 deletions may represent 50% of the overall mutational spectrum of the four MMR genes causing Lynch syndrome.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22781090      PMCID: PMC3548257          DOI: 10.1038/ejhg.2012.150

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  25 in total

1.  Haploview: analysis and visualization of LD and haplotype maps.

Authors:  J C Barrett; B Fry; J Maller; M J Daly
Journal:  Bioinformatics       Date:  2004-08-05       Impact factor: 6.937

2.  Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC).

Authors:  Heleen van der Klift; Juul Wijnen; Anja Wagner; Paul Verkuilen; Carli Tops; Robyn Otway; Maija Kohonen-Corish; Hans Vasen; Cristina Oliani; Daniela Barana; Pal Moller; Celia Delozier-Blanchet; Pierre Hutter; William Foulkes; Henry Lynch; John Burn; Gabriela Möslein; Riccardo Fodde
Journal:  Genes Chromosomes Cancer       Date:  2005-10       Impact factor: 5.006

3.  Germline novel MSH2 deletions and a founder MSH2 deletion associated with anticipation effects in HNPCC.

Authors:  A Stella; N C Surdo; P Lastella; D Barana; C Oliani; M G Tibiletti; A Viel; C Natale; A Piepoli; G Marra; G Guanti
Journal:  Clin Genet       Date:  2007-02       Impact factor: 4.438

4.  Origins and prevalence of the American Founder Mutation of MSH2.

Authors:  Mark Clendenning; Mark E Baze; Shuying Sun; Kyle Walsh; Sandya Liyanarachchi; Dan Fix; Victoria Schunemann; Ilene Comeras; Molly Deacon; Jane F Lynch; Gordon Gong; Brittany C Thomas; Stephen N Thibodeau; Henry T Lynch; Heather Hampel; Albert de la Chapelle
Journal:  Cancer Res       Date:  2008-04-01       Impact factor: 12.701

5.  Identification of predictive factors for the occurrence of predisposing MLH1 and MSH2 germline mutations among Sardinian patients with colorectal carcinoma.

Authors:  Maria Colombino; Antonio Cossu; Mario Budroni; Maria P Satta; Paola Baldinu; Milena Casula; Grazia Palomba; Marina Pisano; Maria C Sini; Angelo Deiana; Francesco Tanda; Giuseppe Palmieri
Journal:  Eur J Cancer       Date:  2005-05       Impact factor: 9.162

6.  A common MSH2 mutation in English and North American HNPCC families: origin, phenotypic expression, and sex specific differences in colorectal cancer.

Authors:  N J Froggatt; J Green; C Brassett; D G Evans; D T Bishop; R Kolodner; E R Maher
Journal:  J Med Genet       Date:  1999-02       Impact factor: 6.318

7.  Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer).

Authors:  Heather Hampel; Wendy L Frankel; Edward Martin; Mark Arnold; Karamjit Khanduja; Philip Kuebler; Hidewaki Nakagawa; Kaisa Sotamaa; Thomas W Prior; Judith Westman; Jenny Panescu; Dan Fix; Janet Lockman; Ilene Comeras; Albert de la Chapelle
Journal:  N Engl J Med       Date:  2005-05-05       Impact factor: 91.245

Review 8.  A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.

Authors:  C R Boland; S N Thibodeau; S R Hamilton; D Sidransky; J R Eshleman; R W Burt; S J Meltzer; M A Rodriguez-Bigas; R Fodde; G N Ranzani; S Srivastava
Journal:  Cancer Res       Date:  1998-11-15       Impact factor: 12.701

9.  Distinct patterns of germ-line deletions in MLH1 and MSH2: the implication of Alu repetitive element in the genetic etiology of Lynch syndrome (HNPCC).

Authors:  Lili Li; Susan McVety; Rami Younan; Ping Liang; Desirée Du Sart; Philip H Gordon; Pierre Hutter; Frans B L Hogervorst; George Chong; William D Foulkes
Journal:  Hum Mutat       Date:  2006-04       Impact factor: 4.878

10.  Optimization of antibodies for detection of the mismatch repair proteins MLH1, MSH2, MSH6, and PMS2 using a biotin-free visualization system.

Authors:  Tine Plato Hansen; Ole Nielsen; Claus Fenger
Journal:  Appl Immunohistochem Mol Morphol       Date:  2006-03
View more
  4 in total

Review 1.  Genetic predisposition to colorectal cancer: where we stand and future perspectives.

Authors:  Laura Valle
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

2.  A founder MLH1 mutation in Lynch syndrome families from Piedmont, Italy, is associated with an increased risk of pancreatic tumours and diverse immunohistochemical patterns.

Authors:  Iolanda Borelli; Guido C Casalis Cavalchini; Serena Del Peschio; Monica Micheletti; Tiziana Venesio; Ivana Sarotto; Anna Allavena; Luisa Delsedime; Marco A Barberis; Giorgia Mandrile; Paola Berchialla; Paola Ogliara; Cecilia Bracco; Barbara Pasini
Journal:  Fam Cancer       Date:  2014-09       Impact factor: 2.375

3.  A survey of the clinicopathological and molecular characteristics of patients with suspected Lynch syndrome in Latin America.

Authors:  Benedito Mauro Rossi; Edenir Inêz Palmero; Francisco López-Kostner; Carlos Sarroca; Carlos Alberto Vaccaro; Florencia Spirandelli; Patricia Ashton-Prolla; Yenni Rodriguez; Henrique de Campos Reis Galvão; Rui Manuel Reis; André Escremim de Paula; Luis Gustavo Capochin Romagnolo; Karin Alvarez; Adriana Della Valle; Florencia Neffa; Pablo German Kalfayan; Enrique Spirandelli; Sergio Chialina; Melva Gutiérrez Angulo; Maria Del Carmen Castro-Mujica; Julio Sanchez de Monte; Richard Quispe; Sabrina Daniela da Silva; Norma Teresa Rossi; Claudia Barletta-Carrillo; Susana Revollo; Ximena Taborga; L Lena Morillas; Hélène Tubeuf; Erika Maria Monteiro-Santos; Tamara Alejandra Piñero; Constantino Dominguez-Barrera; Patrik Wernhoff; Alexandra Martins; Eivind Hovig; Pål Møller; Mev Dominguez-Valentin
Journal:  BMC Cancer       Date:  2017-09-05       Impact factor: 4.430

4.  Multiple-integrations of HPV16 genome and altered transcription of viral oncogenes and cellular genes are associated with the development of cervical cancer.

Authors:  Xulian Lu; Qiaoai Lin; Mao Lin; Ping Duan; Lulu Ye; Jun Chen; Xiangmin Chen; Lifang Zhang; Xiangyang Xue
Journal:  PLoS One       Date:  2014-07-03       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.